Xenon Pharmaceuticals Insider Trades

XENE

Track insider trading activity from Xenon Pharmaceuticals executives and directors. See which insiders are buying and selling XENE stock.

Trades Last 12 Months

XENE Price

All Insider Trades for Xenon Pharmaceuticals

Sort by: Latest Trade Biggest Holding
Insider
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Svoronos Dawn Director
Holding Value $1.17M 31,373 shares
Last Trade
Sep 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$309k 5,144 shares
$60.00
$37.25
Kenney Christopher John Chief Medical Officer
Holding Value $26.1k 702 shares
Last Trade
Aug 28, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$426k 7,068 shares
$60.25
$37.25
Gannon Steven Director
Holding Value $69.7k 1,870 shares
Last Trade
Aug 11, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$641k 10,000 shares
$64.06
$37.25
Cannon Gillian Director
Holding Value $54.2k 1,455 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$63.2k 1,190 shares
$53.14
$37.25
Patou Gary Director
Holding Value $927k 24,896 shares
Last Trade
Jun 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.3k 1,322 shares
$53.14
$37.25
Holding Value $391k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$37.25
Machado Patrick Director
Holding Value $391k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$37.25
Gover Justin D. Director
Holding Value $391k 10,507 shares
Last Trade
Jun 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$647k 12,100 shares
$53.46
$37.25
Gannon Steven Director
Holding Value $396k 10,641 shares
Last Trade
May 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$193k 3,500 shares
$55.00
$37.25
Kenney Christopher John Chief Medical Officer
Holding Value $263k 7,069 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$77.9k 1,410 shares
$55.23
$37.25
Di Fabio Andrea Chief Legal Officer
Holding Value $272k 7,301 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$74.1k 1,342 shares
$55.23
$37.25
Mortimer Ian PRESIDENT & CEO
Holding Value $742k 19,923 shares
Last Trade
Mar 13, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$404k 7,308 shares
$55.23
$37.25
Cline Darren S Chief Commercial Officer
Holding Value $1.49M 40,000 shares
Last Trade
Jan 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.53M 60,000 shares
$42.15
$37.25
Kelly Thomas Patrick Chief Financial Officer
Holding Value $8.38M 225,000 shares
Last Trade
Oct 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$9.43M 225,000 shares
$41.90
$37.25
Holding Value $634k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$37.25
Patou Gary Director
Holding Value $634k 17,012 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$523k 17,012 shares
$30.73
$37.25
Difabio Andrea Chief Legal Officer
Holding Value $2.98M 80,000 shares
Last Trade
Mar 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.84M 80,000 shares
$35.48
$37.25
Aulin Sherry Chief Financial Officer
Holding Value $224k 6,000 shares
Last Trade
Dec 18, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.05M 25,334 shares
$41.28
$37.25
Empfield James R. Evp, Drug Discovery
Holding Value $2.42M 65,000 shares
Last Trade
Mar 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 65,000 shares
$44.37
$37.25
Robin Sherrington Evp, Strategy & Innovation
Holding Value $2.42M 65,000 shares
Last Trade
Mar 11, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.88M 65,000 shares
$44.37
$37.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up